SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-003189
Filing Date
2017-05-01
Accepted
2017-05-01 17:12:33
Documents
43
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20170331x10q.htm 10-Q 911547
2 EX-31.1 mrns-20170331ex3112dc7eb.htm EX-31.1 15227
3 EX-31.2 mrns-20170331ex312e86992.htm EX-31.2 15370
4 EX-32.1 mrns-20170331ex3217dda57.htm EX-32.1 9458
5 GRAPHIC mrns20170331x10q001.jpg GRAPHIC 23678
  Complete submission text file 0001558370-17-003189.txt   2612156

Data Files

Seq Description Document Type Size
6 EX-101.INS mrns-20170331.xml EX-101.INS 364791
7 EX-101.SCH mrns-20170331.xsd EX-101.SCH 18978
8 EX-101.CAL mrns-20170331_cal.xml EX-101.CAL 24775
9 EX-101.DEF mrns-20170331_def.xml EX-101.DEF 57854
10 EX-101.LAB mrns-20170331_lab.xml EX-101.LAB 200787
11 EX-101.PRE mrns-20170331_pre.xml EX-101.PRE 137500
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 17801807
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences